Solve2winsp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-04-02
Share capital
7,000.00 PLN
Registered address
ul. Sudecka 145B, 53-128 Wrocław, Poland
Electronic delivery address
AE:PL-24672-55563-SSTJW-30

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 350 days for 2021).

  • 2025not filed
  • 202418/05/2026
  • 202314/01/2025
  • 202224/07/2023
  • 202130/06/2023
  • 202027/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Division · Human health activities708 / 2,928
Top 24%
Top 24%
Voivodeship · Dolnośląskie14,243 / 41,332
Top 34%
Country · Poland179,300 / 495,866
Top 36%

Results vs industry

Revenue
This companyUSD 447.73kMedianUSD 91.71kAverageUSD 1.38m
Net profit
This companyUSD -4.31kMedianUSD 2.61kAverageUSD 145.69k
Operating costs
This companyUSD 448.40kMedianUSD 82.81kAverageUSD 1.18m
Assets
This companyUSD 44.48kMedianUSD 39.25kAverageUSD 949.40k

Authorized Representatives

Agnieszka Krystyna Nomejko – President of the Management Board
Idalia Joanna Mazurec – Vice President of the Management Board

Manner of representation

Each member of the management board is authorized to represent the company.

Ownership

OwnerSharesShare valueStake
Idalia Joanna Mazurecage 54
70$945.4350%
Agnieszka Krystyna Nomejkoage 40
70$945.4350%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$668
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$792
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$744

Competitors

Name
EQSsp. z o.o.
LabplusS.A.
WMC PietryszynS.K.A.
Kirei Clinicsp. z o.o.
Kmalkosp. z o.o.
8DT Klinikasp. z o.o.
Instytut Diagnostyki Molekularnej Diagmolsp. z o.o.
Kmnikosp. z o.o.
SMD Consultingsp. z o.o.
Esdent Diagnostykasp. z o.o.

FAQ

Last updated: 2026-05-18